RayOne EMV

Now available as a toric IOL

Premium IOL solutions for your patients

Discover how RayOne EMV and RayOne EMV Toric can fit into your premium IOL offering

“For many years I have worked on optimising a lens for monovision, given that it accounts for nearly 30% of all surgeries. I collaborated with Rayner on bringing this lens to market as RayOne EMV, an exciting new product for all surgeons looking to treat presbyopia reliably”

Professor Graham Barrett,

President of the Australasian Society of Cataract & Refractive Surgeons

How does RayOne EMV work?

Centre region

Induced positive spherical aberration

Blended edge region

Reduced longitudinal spherical aberration designed to maintain visual acuity and constrast sensitivity under mesopic conditions.

Visual diagram explaining how the EMV system works with dots for clarity
1

The patented RayOne EMV optic maintains monofocal-quality distance vision

2

RayOne EMV uniquely redirects light BOTH myopically to extend depth of focus for excellent intermediate vision AND hyperopically for a wider landing zone

3

This unique hyperopic extended depth design also provides enhanced blended binocular vision when used in a monovision configuration

1

Offsetting the second eye for monovision

2

The depth of field now reaches past intermediate to also provide functional near vision

3

The hyperopic extension of the unique patented +SA

1

Offsetting the second eye for monovision

2

The depth of field now reaches past intermediate to also provide functional near vision

3

The hyperopic extension of the unique patented +SA

1

Offsetting the second eye for monovision

2

The depth of field now reaches past intermediate to also provide functional near vision

3

The hyperopic extension of the unique patented +SA

1

Offsetting the second eye for monovision

2

The depth of field now reaches past intermediate to also provide functional near vision

3

The hyperopic extension of the unique patented +SA

With RayOne EMV Toric you can correct more of your patients, even those with significant corneal astigmatism

Proven rotational stability and centration8 with predictable, sustainable and accurate visual results

  • Average offset of only 0.08 mm 3 to 6 months after surgery8
  • 1.83° mean IOL rotation 3 to 6 months after surgery8
  • Available in a wide range of IOL plane cylinders: +0.75 D to +4.5 D, in +0.75 D increments

 

Clinical results with RayOne EMV

Comparative outcomes with RayOne EMV

At the Hospital da Luz Lisboa in Lisbon, Professor Filomena Ribeiro and Professor Tiago Ferreira led a 150 patient double-arm, non-randomised prospective case series where RayOne EMV demonstrated excellent visual outcomes for distance and intermediate vision, and good visual acuity for near vision.1

RayOne EMV versus TECNIS Eyhance

At the Hospital San Rafael in Madrid, 22 eyes of 11 patients were implanted with RayOne EMV and 70 eyes of 35 patients implanted with TECNIS Eyhance (Johnson & Johnson Vision). Bilateral emmetropia was targeted for all patients. The defocus curve reports the binocular vision obtained using the best distance correction.6

Monovision outcomes with RayOne EMV

At the Tan Tock Seng Hospital in Singapore, Dr Tun Kuan Yeo demonstrated the binocular impact of positive spherical aberration by combining RayOne EMV with 1.5 D of monovision. The study showed similar performance for both photopic and mesopic conditions.

RayOne EMV Toric multicentre real world clinical results

Results from a multicentre evaluation involving 16 surgeons across eight countries and 56 patients (89 eyes) show that RayOne EMV Toric offers:

  • Uncorrected distance visual acuity (UDVA) similar to that expected from a standard monofocal IOL
  • Range of vision extension with excellent uncorrected intermediate visual acuity (UIVA) values
  • Very good functional uncorrected near visual acuity (UNVA) outcomes
  • Significant cylinder reduction
  • Predictable refractive accuracy
  • The lens was observed to be rotationally stable.
  • High patient satisfaction and spectacle independence rates


“RayOne EMV can easily be the lens that helps surgeons go from being a standard lens surgeon to a premium lens surgeon. It is a natural, easy transition for most surgeons to make, and it provides patients with good quality distance and intermediate vision along with useful near vision for many, particularly with a mini-monovision approach.”

Mr Allon Barsam
Consultant Ophthalmic Surgeon & Director at OCL Vision

 

  • Single piece IOL created from a homogeneous material free of microvacuoles1
  • Compressible material for delivery through a 2.2 mm micro incision
  • Excellent handling characteristics with controlled unfolding within the capsular bag
  • Low silicone oil adherence2
  • Excellent uveal biocompatibility3
  • Hydrophilic acrylic material with low inflammatory response4
  • 11 million Rayacryl hydrophilic IOL implantations

 

 

  1. Rayner. Data on File (RDTR 1937).
  2. McLoone E, Mahon G, Archer D, Best R. Br J Ophthalmol. 2001; 85:543-545.
  3. Tomlins PJ, Sivaraj RR, Rauz S, Denniston AK, Murray PI. J Cataract Refract Surg. 2014; 40:618-625.
  4. Rayner. Data on File.

 

  • Proven rotational stability and centration8 with predictable, sustainable and accurate visual results.
  • Average offset of only 0.08 mm 3 to 6 months after surgery8
  • 1.83° mean IOL rotation 3 to 6 months after surgery8

  1. Outer haptics begin to take up the compression forces of post-operative capsule contraction
  2. Outer haptics engage the inner haptics
  3. Haptic tips gently meet the IOL optic and are effectively locked into position

 

Videos

Articles & downloads

Learn more about RayOne EMV

This field is for validation purposes and should be left unchanged.
  1. Ferreira TB. Presented at ESCRS 2022.
  2. RayOne EMV: First Clinical Results, Rayner. Oct 2020.
  3. Rayner RayPRO, data on file.
  4. Rayner, data on file.
  5. Rayner Peer2Peer webinar. May 2022.
  6. Royo, M. RayOne EMV and TECNIS Eyhance: A Comparative Clinical Defocus Curve. Data on file. 2021.
  7. How to Choose the Right Solution for Your Patients, CRSTE April 2021.
  8. Bhogal-Bhamra GK, Sheppard AL, Kolli S, Wolffsohn JS. J Refract Surg. 2019;35(1):48-53.

Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners.